Gross Profit Trends Compared: Biogen Inc. vs Alkermes plc

Biogen vs Alkermes: A Decade of Diverging Profits

__timestampAlkermes plcBiogen Inc.
Wednesday, January 1, 20141709140008532288000
Thursday, January 1, 20151449420009523400000
Friday, January 1, 20162264240009970100000
Sunday, January 1, 201733573700010643900000
Monday, January 1, 201849244800011636600000
Tuesday, January 1, 201947772900012422500000
Wednesday, January 1, 202046585200011639400000
Friday, January 1, 20215698380008872000000
Saturday, January 1, 20228936870007895100000
Sunday, January 1, 202314103680007302200000
Monday, January 1, 202413123010009675900000
Loading chart...

Cracking the code

Gross Profit Trends: Biogen Inc. vs Alkermes plc

In the ever-evolving landscape of biotechnology, understanding financial trends is crucial. Over the past decade, Biogen Inc. and Alkermes plc have showcased contrasting trajectories in their gross profit margins. From 2014 to 2023, Biogen's gross profit peaked in 2019, reaching approximately 12% higher than its 2014 figures. However, a notable decline followed, with a 41% drop by 2023. In contrast, Alkermes plc demonstrated a remarkable upward trend, with its gross profit surging by over 700% from 2014 to 2023. This divergence highlights the dynamic nature of the biotech industry, where strategic decisions and market conditions can lead to vastly different financial outcomes. As investors and stakeholders analyze these trends, the data underscores the importance of agility and innovation in maintaining competitive advantage.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025